Portfolio company
ESSA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This pharmaceutical company develops therapies for the treatment of prostate cancer for patients with advanced disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alessa Therapeutics
This company develops a drug-delivery platform for the localized release of therapies to treat patients with early-stage prostate cancer.
NXThera
This company develops water vapour therapy systems to treat patients suffering from enlarged prostate and prostate cancer.
Blue Earth
This company develops molecular imaging agents and radiopharmaceutical therapies for healthcare professionals to diagnose and treat patients with prostate cancer.
RYZB
This company develops targeted radiopharmaceutical therapeutics for patients with solid tumours.
Convergent Tx
This clinical-stage biotechnology company develops targeted radiopharmaceutical therapies for patients with prostate cancer and other solid tumours.
NuCana
This biopharmaceutical company develops advanced medicines using phosphoramidate chemistry to treat patients with various forms of cancer.
Gossamer Bio
This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.
Forma
This company develops small molecule therapies for patients with sickle cell disease and cancer.
